Bill Thomas

Bill Thomas is the current Director of Med Chem at Atomwise. Prior to this, they were a Principal Scientist at REVOLUTION Medicines from May 2020 to March 2021. Before that, they were a medicinal chemist at Pharmacyclics from June 2014 to May 2020, and a Scientist II at Cytokinetics from October 2013 to May 2014. From August 2009 to September 2013, they were a Senior Scientist at Nanosyn, and from March 2009 to June 2009, they were a Senior Scientist at Kimia. Bill was also an Assistant Senior Scientist at Telik, Inc. from October 2007 to March 2009, and a Scientist II at ChemoCentryx from April 2005 to October 2007. Bill began their career as a Scientist at Gilead Sciences from April 2003 to April 2005.

Bill Thomas received their PhD in Chemistry from the University of Wisconsin-Madison and their BS in Chemistry from Brigham Young University.

Some individuals on their team include Shahab Mortezaei - Associate Principal Scientist, Med Chem, Kyle Giesler - Senior Scientist, Med Chem, and Cheng Hu - Associate Director, Med Chem. Their manager is Gavin Hirst, Chief Scientific Officer. Some of their coworkers include Pamela Tsuruda - VP, Biology, Henry Van Den Bedem - VP, ML Cheminformatics & Research, and Jordi Silvestre-Ryan - Scientist, Cheminformatics.